Turn Simple AI Image...
Everything Else
Cellomatics BioSciences introduces advanced in vitro models to accelerate drug discovery for Non-Alcoholic Steatohepatitis (NASH). The company’s specialized scientific team delivers precise, reliable assay systems that successfully replicate complex hepatic disease mechanisms. These consist of steatosis, inflammation, metabolic tension, and fibrosis. They provide not only accurate lipid quantification, promising biomarker data, and robust validation data to significantly empower global innovators in the ******ceutical and biotech sectors. The rigorous simulation of human disease progression provided by these models enhances early-stage efficacy testing of novel therapeutics. Partners trust Cellomatics to streamline workflows and expedite critical pipelines. Explore their comprehensive NASH research solutions by visiting their website today.







